{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:08:29Z","timestamp":1790251709990,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001104-00"],"award-info":[{"award-number":["MOH-001104-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001575-00"],"award-info":[{"award-number":["MOH-001575-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001575-00"],"award-info":[{"award-number":["MOH-001575-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41375-026-03043-9","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:47:24Z","timestamp":1784101644000},"page":"2143-2156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA methylation signatures distinguish extranodal NK\/T-cell lymphoma and EBV-positive nodal T\/NK-cell lymphoma and identify prognostic subgroups"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-6118","authenticated-orcid":false,"given":"The","family":"Phyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Mun","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-2544","authenticated-orcid":false,"given":"Anja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-8216","authenticated-orcid":false,"given":"Henry","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2025-9667","authenticated-orcid":false,"given":"Lichang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis Ching Yi","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-525X","authenticated-orcid":false,"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-3584","authenticated-orcid":false,"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-0579","authenticated-orcid":false,"given":"Young-Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Hon Kim","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-3703","authenticated-orcid":false,"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-1551","authenticated-orcid":false,"given":"Ling-Wen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-6410","authenticated-orcid":false,"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3043_CR1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","volume":"107","author":"CMM Wai","year":"2022","unstructured":"Wai CMM, Chen S, Phyu T, Fan S, Leong SM, Zheng W, et al. Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS. Haematologica. 2022;107:1864\u201379.","journal-title":"Haematologica"},{"key":"3043_CR2","unstructured":"Chuang S-S, Cheng CL, Huang YH, Kwong YL, Li GD, Ng S-B, et al. Extranodal NK\/T-cell lymphoma. In: WHO Classification of Tumours Editorial Board, editors. WHO Classification of Tumours: Haematolymphoid Tumours. 5th ed. Lyon: International Agency for Research on Cancer. 2024."},{"key":"3043_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrc.2015.4","volume":"16","author":"PA Jeggo","year":"2015","unstructured":"Jeggo PA, Pearl LH, Carr AM. DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer. 2015;16:35\u201342.","journal-title":"Nat Rev Cancer"},{"key":"3043_CR4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies A, Zoubeidi A, Beltran H, Selth LA. The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov. 2023;13:1771\u201388.","journal-title":"Cancer Discov"},{"key":"3043_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1191311","volume":"14","author":"J Imamura","year":"2023","unstructured":"Imamura J, Ganguly S, Muskara A, Liao RS, Nguyen JK, Weight C, et al. Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. Front Endocrinol. 2023;14:1191311.","journal-title":"Front Endocrinol"},{"key":"3043_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919900856","volume":"12","author":"C K\u00fc\u00e7\u00fck","year":"2020","unstructured":"K\u00fc\u00e7\u00fck C, Wang J, Xiang Y, You H. Epigenetic aberrations in natural killer\/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. Ther Adv Med Oncol. 2020;12:1758835919900856.","journal-title":"Ther Adv Med Oncol"},{"key":"3043_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","volume":"12","author":"S de Mel","year":"2019","unstructured":"de Mel S, Hue SSS, Jeyasekharan AD, Chng WJ, Ng SB. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J Hematol Oncol. 2019;12:33.","journal-title":"J Hematol Oncol"},{"key":"3043_CR8","volume":"62","author":"WL Chan","year":"2025","unstructured":"Chan WL, Hue SSS, Deng L, Leong SM, Chng WJ, Ng SB. Extranodal NK\/T-cell lymphoma: an update of the molecular characterization of the tumor and microenvironment, and its clinical implications. Lancet Reg Health West Pac. 2025;62:101550.","journal-title":"Lancet Reg Health West Pac"},{"key":"3043_CR9","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","volume":"21","author":"C K\u00fc\u00e7\u00fck","year":"2015","unstructured":"K\u00fc\u00e7\u00fck C, Hu X, Jiang B, Klinkebiel D, Geng H, Gong Q, et al. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clin Cancer Res. 2015;21:1699\u2013711.","journal-title":"Clin Cancer Res"},{"key":"3043_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hon.2362","volume":"35","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Liang L, Li D, Nong L, Liu J, Qu L, et al. Hypermethylation of PRDM1\/Blimp-1 promoter in extranodal NK\/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation. Hematol Oncol. 2017;35:645\u201354.","journal-title":"Hematol Oncol"},{"key":"3043_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2643-3230.BCD-21-0098","volume":"3","author":"BL Mundy-Bosse","year":"2022","unstructured":"Mundy-Bosse BL, Weigel C, Wu YZ, Abdelbaky S, Youssef Y, Casas SB, et al. Identification and targeting of the developmental blockade in extranodal natural killer\/T-cell lymphoma. Blood Cancer Discov. 2022;3:154\u201369.","journal-title":"Blood Cancer Discov"},{"key":"3043_CR12","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/bloodadvances.2023012019","volume":"8","author":"S Kato","year":"2024","unstructured":"Kato S, Hamada M, Okamoto A, Yamashita D, Miyoshi H, Arai H, et al. EBV+ nodal T\/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. Blood Adv. 2024;8:2138\u201347.","journal-title":"Blood Adv"},{"key":"3043_CR13","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1038\/s41596-019-0202-2","volume":"14","author":"SY Shen","year":"2019","unstructured":"Shen SY, Burgener JM, Bratman SV, De Carvalho DD. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA. Nat Protoc. 2019;14:2749\u201380.","journal-title":"Nat Protoc"},{"key":"3043_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563:579\u201383.","journal-title":"Nature"},{"key":"3043_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100859","volume":"4","author":"XP Tian","year":"2023","unstructured":"Tian XP, Zhang YC, Lin NJ, Wang L, Li ZH, Guo HG, et al. Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer\/T cell lymphoma. Cell Rep Med. 2023;4:100859.","journal-title":"Cell Rep Med"},{"key":"3043_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","volume":"160","author":"LLP Siu","year":"2002","unstructured":"Siu LLP, Chan JKC, Wong KF, Kwong YL. Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol. 2002;160:59\u201366.","journal-title":"Am J Pathol"},{"key":"3043_CR17","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010\u201322.","journal-title":"Genes Dev"},{"key":"3043_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r37","volume":"15","author":"JR Wagner","year":"2014","unstructured":"Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 2014;15:R37.","journal-title":"Genome Biol"},{"key":"3043_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303913","volume":"10","author":"YQ Li","year":"2023","unstructured":"Li YQ, Luo CL, Jiang JX, He S, Liu Y, Yan WX, et al. Single-cell analysis reveals malignant cells reshape the cellular landscape and foster an immunosuppressive microenvironment of extranodal NK\/T-cell lymphoma. Adv Sci. 2023;10:e2303913.","journal-title":"Adv Sci"},{"key":"3043_CR20","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/cncr.30697","volume":"123","author":"JA Vargo","year":"2017","unstructured":"Vargo JA, Patel A, Glaser SM, Balasubramani GK, Farah RJ, Marks SM, et al. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States. Cancer. 2017;123:3176\u201385.","journal-title":"Cancer"},{"key":"3043_CR21","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1093\/hmg\/ddm018","volume":"16","author":"M Esteller","year":"2007","unstructured":"Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007;16:R50\u20139.","journal-title":"Hum Mol Genet"},{"key":"3043_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00428-023-03616-4","volume":"483","author":"F Climent","year":"2023","unstructured":"Climent F, Nicolae A, de Leval L, Dirnhofer S, Leoncini L, Ondrejka SL, et al. Cytotoxic peripheral T-cell lymphomas and EBV-positive T\/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP\/SH lymphoma workshop. Virchows Arch. 2023;483:333\u201348.","journal-title":"Virchows Arch"},{"key":"3043_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito S, D\u2019Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466:1129\u201333.","journal-title":"Nature"},{"key":"3043_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2025.195118","volume":"1868","author":"T Aanniz","year":"2025","unstructured":"Aanniz T, El Fessikh M, Touhtouh J, Aboulaghras S, El Omari N, Khalid A, et al. TET enzymes: Involvement in cancer development and therapeutical perspectives. Biochim Biophys Acta Gene Regul Mech. 2025;1868:195118.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"3043_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nature21373","volume":"543","author":"F Neri","year":"2017","unstructured":"Neri F, Rapelli S, Krepelova A, Incarnato D, Parlato C, Basile G, et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature. 2017;543:72\u20137.","journal-title":"Nature"},{"key":"3043_CR26","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14:1783\u2013809.","journal-title":"Cancer Discov"},{"key":"3043_CR27","volume":"2017","author":"P Zhang","year":"2017","unstructured":"Zhang P, Lehmann BD, Shyr Y, Guo Y. The utilization of formalin fixed-paraffin-embedded specimens in high throughput genomic studies. Int J Genom. 2017;2017:1926304.","journal-title":"Int J Genom"},{"key":"3043_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17:208.","journal-title":"Genome Biol"},{"key":"3043_CR29","doi-asserted-by":"publisher","first-page":"e50233","DOI":"10.1371\/journal.pone.0050233","volume":"7","author":"C Clark","year":"2012","unstructured":"Clark C, Palta P, Joyce CJ, Scott C, Grundberg E, Deloukas P, et al. A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the Infinium HumanMethylation450 BeadChip(\u00ae) for methylome profiling. PLoS One. 2012;7:e50233.","journal-title":"PLoS One"},{"key":"3043_CR30","doi-asserted-by":"publisher","unstructured":"Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Delegard J, et al. Analysis of gliomas DNA methylation: assessment of pre-analytical variables [Internet]. bioRxiv. 2024. Available from: https:\/\/doi.org\/10.1101\/2024.03.26.586350.","DOI":"10.1101\/2024.03.26.586350"},{"key":"3043_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/15592294.2021.1924970","volume":"17","author":"D Beck","year":"2022","unstructured":"Beck D, Ben Maamar M, Skinner MK. Genome-wide CpG density and DNA methylation analysis method (MeDIP, RRBS, and WGBS) comparisons. Epigenetics. 2022;17:518\u201330.","journal-title":"Epigenetics"},{"key":"3043_CR32","doi-asserted-by":"publisher","unstructured":"de Mel S, Soon GST, Mok Y, Chung TH, Jeyasekharan AD, Chng WJ, et al. The genomics and molecular biology of natural killer\/T-cell lymphoma: opportunities for translation. Int J Mol Sci [Internet]. 2018;19. Available from: https:\/\/doi.org\/10.3390\/ijms19071931.","DOI":"10.3390\/ijms19071931"},{"key":"3043_CR33","first-page":"6390","volume":"62","author":"T Oka","year":"2002","unstructured":"Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatani Y, et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas. Cancer Res. 2002;62:6390\u20134.","journal-title":"Cancer Res"},{"key":"3043_CR34","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1182\/blood.V122.21.2497.2497","volume":"122","author":"K Nie","year":"2013","unstructured":"Nie K, Zhang T, Yan J, Boiocchi L, Cheng S, Mathew S, et al. Inactivation Of BANK1 By a Novel IGH-Associated Translocation and 5\u2019 Hypermethylation In B-Cell Lymphomas. Blood. 2013;122:2497\u20132497.","journal-title":"Blood"},{"key":"3043_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.36","volume":"4","author":"J Yan","year":"2014","unstructured":"Yan J, Nie K, Mathew S, Tam Y, Cheng S, Knowles DM, et al. Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma. Blood Cancer J. 2014;4:e215.","journal-title":"Blood Cancer J"},{"key":"3043_CR36","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-10-0356","volume":"16","author":"L Gattinoni","year":"2010","unstructured":"Gattinoni L, Ji Y, Restifo NP. Wnt\/beta-catenin signaling in T-cell immunity and cancer immunotherapy. Clin Cancer Res. 2010;16:4695\u2013701.","journal-title":"Clin Cancer Res"},{"key":"3043_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/ejh.13836","volume":"109","author":"C Qiu","year":"2022","unstructured":"Qiu C, Du G. Loss of LEF-1 expression as a diagnostic indicator for extranodal NK\/T-cell lymphoma: An immunohistochemical study of 88 cases. Eur J Haematol. 2022;109:513\u20138.","journal-title":"Eur J Haematol"},{"key":"3043_CR38","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1007\/s10620-021-07051-w","volume":"67","author":"Y Qi","year":"2022","unstructured":"Qi Y, Shan Y, Li S, Huang Y, Guo Y, Huang T, et al. LncRNA LEF1-AS1\/LEF1\/FUT8 axis mediates colorectal cancer progression by regulating \u03b11, 6-fucosylationvia Wnt\/\u03b2-catenin pathway. Dig Dis Sci. 2022;67:2182\u201394.","journal-title":"Dig Dis Sci"},{"key":"3043_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/107999004322917034","volume":"24","author":"L Tracey","year":"2004","unstructured":"Tracey L, Spiteri I, Ortiz P, Lawler M, Piris MA, Villuendas R. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. J Interferon Cytokine Res. 2004;24:185\u201395.","journal-title":"J Interferon Cytokine Res"},{"key":"3043_CR40","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1016\/j.molimm.2007.03.009","volume":"44","author":"J Ollila","year":"2007","unstructured":"Ollila J, Vihinen M. Immunological systems biology: gene expression analysis of B-cell development in Ramos B-cells. Mol Immunol. 2007;44:3537\u201351.","journal-title":"Mol Immunol"},{"key":"3043_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.625414","volume":"12","author":"P Feng","year":"2021","unstructured":"Feng P, Li H, Pei J, Huang Y, Li G. Identification of a 14-gene prognostic signature for diffuse large B cell lymphoma (DLBCL). Front Genet. 2021;12:625414.","journal-title":"Front Genet"},{"key":"3043_CR42","doi-asserted-by":"publisher","first-page":"e64868","DOI":"10.1371\/journal.pone.0064868","volume":"8","author":"N Smith","year":"2013","unstructured":"Smith N, Tierney R, Wei W, Vockerodt M, Murray PG, Woodman CB, et al. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation. PLoS One. 2013;8:e64868.","journal-title":"PLoS One"},{"key":"3043_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41586-020-2884-6","volume":"588","author":"Lee","year":"2020","unstructured":"Lee, Robinson J, Ma ME, Artadji N, Ahmed MA D, Xiao G, et al. IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. 2020;588:491\u20137.","journal-title":"Nature"},{"key":"3043_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01324-5","volume":"16","author":"Z Chen","year":"2024","unstructured":"Chen Z, Huang H, Hong H, Huang H, Weng H, Yu L, et al. Full-spectral genome analysis of natural killer\/T cell lymphoma highlights impacts of genome instability in driving its progression. Genome Med. 2024;16:48.","journal-title":"Genome Med"},{"key":"3043_CR45","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/s41375-022-01623-z","volume":"36","author":"G Dong","year":"2022","unstructured":"Dong G, Liu X, Wang L, Yin W, Bouska A, Gong Q, et al. Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer\/T-cell lymphoma. Leukemia. 2022;36:2064\u201375.","journal-title":"Leukemia"},{"key":"3043_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47:1061\u20136.","journal-title":"Nat Genet"},{"key":"3043_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.humpath.2018.05.026","volume":"80","author":"HS Huang","year":"2018","unstructured":"Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018;80:145\u201351.","journal-title":"Hum Pathol"},{"key":"3043_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1101\/gad.302364.117","volume":"31","author":"O Laptenko","year":"2017","unstructured":"Laptenko O, Prives C. p53: master of life, death, and the epigenome. Genes Dev. 2017;31:955\u20136.","journal-title":"Genes Dev"},{"key":"3043_CR49","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S1470-2045(16)30148-6","volume":"17","author":"Z Li","year":"2016","unstructured":"Li Z, Xia Y, Feng LN, Chen JR, Li HM, Cui J, et al. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol. 2016;17:1240\u20137.","journal-title":"Lancet Oncol"},{"key":"3043_CR50","doi-asserted-by":"crossref","unstructured":"Deng and Q, Green MR. The role of epigenetic dysregulation in lymphoma biology [Internet]. Precision cancer therapies, Volume 1 - Targeting oncogenic drivers and signaling pathways in lymphoid malignancies. Wiley; 2023. p. 197\u2013208. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9781119819950.ch14","DOI":"10.1002\/9781119819950.ch14"},{"key":"3043_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1101\/gr.125872.111","volume":"22","author":"GC Hon","year":"2012","unstructured":"Hon GC, Hawkins RD, Caballero OL, Lo C, Lister R, Pelizzola M, et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 2012;22:246\u201358.","journal-title":"Genome Res"},{"key":"3043_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmmed.2024.1426454","volume":"4","author":"AH Nwabo Kamdje","year":"2024","unstructured":"Nwabo Kamdje AH, Dongmo Fogang HP, Mimche PN. Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy. Front Mol Med. 2024;4:1426454.","journal-title":"Front Mol Med"},{"key":"3043_CR53","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.2353\/ajpath.2010.100052","volume":"177","author":"PG Murray","year":"2010","unstructured":"Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, et al. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol. 2010;177:1480\u201390.","journal-title":"Am J Pathol"},{"key":"3043_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40164-022-00263-4","volume":"11","author":"X Yang","year":"2022","unstructured":"Yang X, Ma L, Zhang X, Huang L, Wei J. Targeting PD-1\/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia. Exp Hematol Oncol. 2022;11:11.","journal-title":"Exp Hematol Oncol"},{"key":"3043_CR55","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1158\/1078-0432.CCR-05-0267","volume":"11","author":"J Ying","year":"2005","unstructured":"Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, et al. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res. 2005;11:6442\u20139.","journal-title":"Clin Cancer Res"},{"key":"3043_CR56","doi-asserted-by":"publisher","first-page":"e0237554","DOI":"10.1371\/journal.pone.0237554","volume":"16","author":"F Moribe","year":"2021","unstructured":"Moribe F, Nishikori M, Takashima T, Taniyama D, Onishi N, Arima H, et al. Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development. PLoS One. 2021;16:e0237554.","journal-title":"PLoS One"},{"key":"3043_CR57","doi-asserted-by":"publisher","unstructured":"Major A, Porcu P, Haverkos BM. Rational targets of therapy in extranodal NK\/T-cell lymphoma. Cancers [Internet]. 2023;15. Available from: https:\/\/doi.org\/10.3390\/cancers15051366.","DOI":"10.3390\/cancers15051366"},{"key":"3043_CR58","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00277-023-05359-3","volume":"102","author":"C Gong","year":"2023","unstructured":"Gong C, Wu J, Song W, Li H, Shi C, Gao Y, et al. Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer\/T-cell lymphoma. Ann Hematol. 2023;102:2845\u201355.","journal-title":"Ann Hematol"},{"key":"3043_CR59","doi-asserted-by":"crossref","unstructured":"Ichikawa S, Fukuhara N, Katsuoka Y, Ishizawa Y, Kamata K, Fukatsu M, et al. Dismal outcome of EBV-positive nodal T\/NK-cell lymphoma: a multicenter retrospective study. Clin Lymphoma Myeloma Leuk [Internet]. 2025; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025042946.","DOI":"10.1016\/j.clml.2025.11.008"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03043-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03043-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03043-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:43:24Z","timestamp":1790250204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03043-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03043-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors confirm that all methods were performed in accordance with the relevant institutional guidelines and regulations. The authors confirm that approval was obtained from the National Healthcare Group Domain Specific Review Board B [2009\/00212]. A waiver of consent was obtained for the use of archival retrospective formalin-fixed paraffin-embedded (FFPE) tissue samples. No live vertebrate studies were performed. No identifiable images are included in this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}